STK11/STRADA/CAB39(LKB1)
Sign in to save this workspaceUniProt STK11:Q15831; STRADA:Q7RTN6; CAB39:Q9Y376 · PDB · AlphaFold · Substrate: LKB1tide · Clone: full length
Top inhibitors
| # | Drug | Inhibition | Residual | KISS | Gini |
|---|---|---|---|---|---|
| 1 | Pacritinib | 76.7% | 23.3% | 88.64 | 0.452 |
| 2 | Repotrectinib | 68.2% | 31.8% | 84.21 | 0.608 |
| 3 | Defactinib | 53.7% | 46.3% | 92.68 | 0.450 |
| 4 | Pralsetinib | 35.2% | 64.8% | 93.43 | 0.643 |
| 5 | Pexidartinib | 34.4% | 65.6% | 99.49 | 0.631 |
| 6 | Pazopanib | 21.2% | 78.8% | 97.49 | 0.672 |
| 7 | Entrectinib | 18.3% | 81.7% | 93.69 | 0.671 |
| 8 | Fostamatinib | 17.6% | 82.4% | 96.74 | 0.613 |
| 9 | Netarsudil | 16.4% | 83.6% | 93.22 | 0.676 |
| 10 | Quizartinib | 14.0% | 86.0% | 99.50 | 0.737 |
| 11 | Canertinib | 12.8% | 87.2% | 96.49 | 0.671 |
| 12 | Zanubrutinib | 11.9% | 88.1% | 98.24 | 0.788 |
| 13 | Capivasertib | 11.5% | 88.5% | 96.48 | 0.644 |
| 14 | Midostaurin | 10.7% | 89.3% | 78.64 | 0.500 |
| 15 | Capmatinib | 10.3% | 89.7% | 99.75 | 0.582 |
| 16 | Sunitinib | 9.4% | 90.6% | 91.73 | 0.524 |
| 17 | Gilteritinib | 9.1% | 90.9% | 88.97 | 0.506 |
| 18 | Umbralisib | 8.0% | 92.0% | 98.74 | 0.670 |
| 19 | Baricitinib | 7.9% | 92.1% | 97.99 | 0.616 |
| 20 | Deucravacitinib | 6.8% | 93.2% | 98.99 | 0.718 |
Paralog block
No paralog group registered for this kinase.
EMT expression
Not in the EMT expression panel.
Selectivity landscape vs inhibition on STK11/STRADA/CAB39
Each point is one of the 92 approved drugs; color = inhibition % on STK11/STRADA/CAB39.
3D structure
Embedded NGL viewer pulls a representative PDB entry (or AlphaFold model if no experimental structure is registered). Heavy bundle — loaded only on demand.
Annotations
Sign in to read and post annotations.
Loading…